Bone marrow transplantation for severe aplastic anaemia. A review of the Westminster experience of 24 cases

Clinical and Laboratory Haematology
J R KendraJ R Hobbs

Abstract

Twenty-four patients have received bone marrow transplantation for severe aplastic anaemia at the Westminster Hospitals since 1974. Twelve patients are long term survivors. Infectious complications in association with graft rejection, graft versus host disease or prolonged neutropenia were the major cause of death. In the last 18 months the introduction of more effective conditioning regimes and Cyclosporin A as graft versus host disease prophylaxis has improved the survival rate to 85%. One patient has required regrafting for late graft failure without evidence of graft rejection.

References

Dec 1, 1975·The British Journal of Dermatology·J H SauratA Puissant
Jan 1, 1979·Clinical and Laboratory Haematology·A J Barrett
Jan 1, 1976·Journal of Immunological Methods·M YamamuraJ R Hobbs
Apr 24, 1975·The New England Journal of Medicine·E D ThomasC D Buckner
Jul 17, 1982·British Medical Journal·A J BarrettK Hugh-Jones
Sep 4, 1980·The New England Journal of Medicine·J A HansenE R Giblett
Jan 1, 1981·Clinical and Laboratory Haematology·J KendraK Hugh-Jones

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

© 2021 Meta ULC. All rights reserved